Topiramate prophylaxis and response to triptan treatment for acute migraine

Headache

Volumn 46, Issue 9, 2006, Pages 1424-1430

  Becker, Werner J ^a,e   Christie, Suzanne N ^b   Ledoux, Stephane ^c   Binder, Carin ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b Ottawa Headache Centre   (Canada)

^c Montreal Migraine Clinic   (Canada)

^d Janssen Ortho Inc   (Canada)

^e FOOTHILLS HOSPITAL   (Canada)

Author keywords

Headache; Migraine; Prophylaxis; Topiramate

Indexed keywords

NARATRIPTAN; RIZATRIPTAN; SUMATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

ABNORMAL THINKING; ABNORMAL VISION; ADULT; AMNESIA; ANOREXIA; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; DIZZINESS; DOSE RESPONSE; DRUG EFFECT; FATIGUE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MENTAL INSTABILITY; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; PARESTHESIA; PRIORITY JOURNAL; SIDE EFFECT; TASTE DISORDER; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ANXIETY DISORDERS; CHILD; CHRONIC DISEASE; COMORBIDITY; HEADACHE; HUMANS; MOOD DISORDERS; PAIN;

EID: 33749660154     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00531.x     Document Type: Article

References (24)

1. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention. JAMA. 2004;291:965-973.
2. Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention. Results of a large controlled trial. Arch Neurol. 2004;61:490-495.
3. Diener HC, Tfelt-Hansen P, Dahlof C, et al., MIGR-003 Study Group. Topiramate in migraine prophylaxis-results from a placebo-controlled trial with propranolol as an active control. J Neurol. 2004;251:943-950.
4. Storey JR, Calder CS, Hart E, Potter DL. Topiramate in migraine prevention: A double-blind, placebo-controlled study. Headache. 2001;41:968-975.
5. Von Seggern RL, Mannix LK, Adelman JU. Efficacy of topiramate in migraine prophylaxis: A retrospective chart analysis. Headache. 2002;42:804-809.
6. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
7. Silberstein SD, for the US Headache Consortium. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754-762.
8. Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex. Arch Neurol. 1995;52:281-286.
9. Klapper J. Divalproex sodium in migraine prophylaxis: A dose-controlled study. Cephalalgia. 1997;17:103-108.
10. Jensen R, Brinck T, Olesen J. Sodium valproate has a prophylactic effect in migraine without aura: A triple-blind, placebo-controlled crossover study. Neurology. 1994;44:647-651.
11. Mathew NT, Rapoport A, Saper J, et al. Efficacy of gabapentin in migraine prophylaxis. Headache. 2000;41:119-128.
12. Spira PJ, Beran RG, and the Australian Gabapentin Chronic Daily Headache Group. Gabapentin in the prophylaxis of chronic daily headache: A randomized placebo-controlled study. Neurology. 2003;61:1753-1759.
13. Ziegler DK, Hurwitz A, Preskorn S, Hassanein R, Seim J. Propranolol and amitriptyline in prophylaxis of migraine. Pharmacokinetic and therapeutic effects. Arch Neurol. 1993;50:825-830.
14. Cleland PG, Barnes D, Elrington GM, Loizou LA, Rawes GD. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone. European Neurol. 1997;38:31-38.
15. Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. Headache. 2000;40:445-450.
16. Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD. Botulinum toxin type A for the prophylaxis of chronic daily headache: Subgroup analysis of patients not receiving other prophylactic medications: A randomized double-blind, placebo-controlled study. Headache. 2005;45:315-324.
17. Newman L, Mannix LK, Landy S, et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: A randomized, double-blind, placebo-controlled study. Headache. 2001;41:248-256.
18. Moschiano F, Allais G, Grazzi L, et al. Naratriptan in the short-term prophylaxis of pure menstrual migraine. Neurol Sci. 2005;26(suppl 2): 162-166, bussone@istituto-besta.it.
19. Silberstein SD, Elkind AH. Schreiber Curtis, Keywood C. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology. 2004;63:261-269.
20. Owada K. Efficacy of candesarten in the treatment of migraine in hypertensive patients. Hypertens Res. 2004;27:441-446.
21. Tonvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: A randomized controlled trial. JAMA. 2003;289:65-69.
22. Brandes JL, Kudrow D, Cady R, et al. Eletriptan in the early treatment of acute migraine: Influence of pain intensity and time of dosing. Cephalalgia. 2005;25: 735-742.
23. Bolay, H, Reuter U, Dunn AK, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002;8:136-142.
24. Haerter K, Ayata C, Moskowitz MA. Cortical spreading depression: A model for understanding migraine biology and future drug targets. Headache Currents. 2005;2:97-103.